Non-immune hydrops after 20 weeks' gestation: Review of 10 years' experience with suggestions for management
To analyze the etiologies and outcomes for a southeastern section of the United States, and to organize an efficient approach to evaluation. We reviewed 82 cases of non-immune hydrops presenting after 20 weeks' gestation over a 10-year period. Overall perinatal mortality was 86.6%. Fetuses diag...
Gespeichert in:
| Veröffentlicht in: | Obstetrics and gynecology (New York. 1953) 1995-04, Vol.85 (4), p.578-582 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 582 |
|---|---|
| container_issue | 4 |
| container_start_page | 578 |
| container_title | Obstetrics and gynecology (New York. 1953) |
| container_volume | 85 |
| creator | Cathleen McCoy, M. Katz, Vern L. Gould, Natalie Kuller, Jeffrey A. |
| description | To analyze the etiologies and outcomes for a southeastern section of the United States, and to organize an efficient approach to evaluation.
We reviewed 82 cases of non-immune hydrops presenting after 20 weeks' gestation over a 10-year period.
Overall perinatal mortality was 86.6%. Fetuses diagnosed with hydrops before 24 weeks' gestation had a perinatal mortality of 95%, with nearly one-third having abnormal karyotypes. The etiology of hydrops diagnosed after 24 weeks' gestation was more likely to remain idiopathic or to be related to cardiothoracic abnormalities.
Before 24 weeks' gestation, the high risk of mortality and abnormal karyotype justifies offering families funipuncture in the hope of finding a treatable cause of non-immune hydrops. After 24 weeks' gestation, when fewer abnormal karyotypes are found, funipuncture may also be pivotal in diagnosing the cause of non-immune hydrops. |
| doi_str_mv | 10.1016/0029-7844(94)00444-I |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77185490</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>002978449400444I</els_id><sourcerecordid>77185490</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3978-10ea495247aa23eeabb67e948ce0195e2f36de78c5d754f5eb6988d3032a0ab53</originalsourceid><addsrcrecordid>eNp9kUuP0zAUhS0EGsrAPwDJC8RjEbiOndpmgYRGPCqNQEIgsbMc56Y1k8TFTgj99zjTquxYWdY55z6-S8hjBq8YsPVrgFIXUgnxQouXAEKIYnOHrJiSvCg5_3GXrM6W--RBSj8Bck7zC3IhlVaKyxXpPoeh8H0_DUh3hyaGfaK2HTHSEuiMeJOe0y2m0Y4-DG_oV_ztcaahpQzoAW3MMv7ZY_Q4OKSzH3c0Tdslkf2JtiHS3g52iz0O40Nyr7Vdwken95J8__D-29Wn4vrLx83Vu-vCcS1VwQCt0FUppLUlR7R1vZaohXIITFdYtnzdoFSuamQl2grrdd6m4cBLC7au-CV5dqy7j-HXlGcxvU8Ou84OGKZkpGSqEhqyURyNLoaUIrZmH31v48EwMAtksxA0C0GjhbmFbDY59uRUf6p7bM6hE9WsPz3pNjnbtdEOzqezjQvFmBD_us-hy8TTTTfNGM0ObTfucjOAdVlBwbSuQORfsdxP5djbYwwzwnyOaJK7xd_4iG40TfD_H_8vphSoNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77185490</pqid></control><display><type>article</type><title>Non-immune hydrops after 20 weeks' gestation: Review of 10 years' experience with suggestions for management</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><creator>Cathleen McCoy, M. ; Katz, Vern L. ; Gould, Natalie ; Kuller, Jeffrey A.</creator><creatorcontrib>Cathleen McCoy, M. ; Katz, Vern L. ; Gould, Natalie ; Kuller, Jeffrey A.</creatorcontrib><description>To analyze the etiologies and outcomes for a southeastern section of the United States, and to organize an efficient approach to evaluation.
We reviewed 82 cases of non-immune hydrops presenting after 20 weeks' gestation over a 10-year period.
Overall perinatal mortality was 86.6%. Fetuses diagnosed with hydrops before 24 weeks' gestation had a perinatal mortality of 95%, with nearly one-third having abnormal karyotypes. The etiology of hydrops diagnosed after 24 weeks' gestation was more likely to remain idiopathic or to be related to cardiothoracic abnormalities.
Before 24 weeks' gestation, the high risk of mortality and abnormal karyotype justifies offering families funipuncture in the hope of finding a treatable cause of non-immune hydrops. After 24 weeks' gestation, when fewer abnormal karyotypes are found, funipuncture may also be pivotal in diagnosing the cause of non-immune hydrops.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>DOI: 10.1016/0029-7844(94)00444-I</identifier><identifier>PMID: 7898837</identifier><identifier>CODEN: OBGNAS</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Algorithms ; Amniocentesis ; Biological and medical sciences ; Delivery, Obstetric - methods ; Diseases of mother, fetus and pregnancy ; Female ; Follow-Up Studies ; Gestational Age ; Gynecology. Andrology. Obstetrics ; Humans ; Hydrops Fetalis - diagnosis ; Hydrops Fetalis - genetics ; Hydrops Fetalis - mortality ; Hydrops Fetalis - physiopathology ; Hydrops Fetalis - therapy ; Infant Mortality ; Infant, Newborn ; Karyotyping ; Male ; Medical sciences ; Parity ; Pregnancy ; Pregnancy Outcome - epidemiology ; Pregnancy. Fetus. Placenta ; Puerperal Disorders - epidemiology ; Survival Rate ; Ultrasonography, Prenatal</subject><ispartof>Obstetrics and gynecology (New York. 1953), 1995-04, Vol.85 (4), p.578-582</ispartof><rights>1995 The American College of Obstetricians and Gynecologists</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3978-10ea495247aa23eeabb67e948ce0195e2f36de78c5d754f5eb6988d3032a0ab53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3481144$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7898837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cathleen McCoy, M.</creatorcontrib><creatorcontrib>Katz, Vern L.</creatorcontrib><creatorcontrib>Gould, Natalie</creatorcontrib><creatorcontrib>Kuller, Jeffrey A.</creatorcontrib><title>Non-immune hydrops after 20 weeks' gestation: Review of 10 years' experience with suggestions for management</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>To analyze the etiologies and outcomes for a southeastern section of the United States, and to organize an efficient approach to evaluation.
We reviewed 82 cases of non-immune hydrops presenting after 20 weeks' gestation over a 10-year period.
Overall perinatal mortality was 86.6%. Fetuses diagnosed with hydrops before 24 weeks' gestation had a perinatal mortality of 95%, with nearly one-third having abnormal karyotypes. The etiology of hydrops diagnosed after 24 weeks' gestation was more likely to remain idiopathic or to be related to cardiothoracic abnormalities.
Before 24 weeks' gestation, the high risk of mortality and abnormal karyotype justifies offering families funipuncture in the hope of finding a treatable cause of non-immune hydrops. After 24 weeks' gestation, when fewer abnormal karyotypes are found, funipuncture may also be pivotal in diagnosing the cause of non-immune hydrops.</description><subject>Adult</subject><subject>Algorithms</subject><subject>Amniocentesis</subject><subject>Biological and medical sciences</subject><subject>Delivery, Obstetric - methods</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gestational Age</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Hydrops Fetalis - diagnosis</subject><subject>Hydrops Fetalis - genetics</subject><subject>Hydrops Fetalis - mortality</subject><subject>Hydrops Fetalis - physiopathology</subject><subject>Hydrops Fetalis - therapy</subject><subject>Infant Mortality</subject><subject>Infant, Newborn</subject><subject>Karyotyping</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Parity</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome - epidemiology</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Puerperal Disorders - epidemiology</subject><subject>Survival Rate</subject><subject>Ultrasonography, Prenatal</subject><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUuP0zAUhS0EGsrAPwDJC8RjEbiOndpmgYRGPCqNQEIgsbMc56Y1k8TFTgj99zjTquxYWdY55z6-S8hjBq8YsPVrgFIXUgnxQouXAEKIYnOHrJiSvCg5_3GXrM6W--RBSj8Bck7zC3IhlVaKyxXpPoeh8H0_DUh3hyaGfaK2HTHSEuiMeJOe0y2m0Y4-DG_oV_ztcaahpQzoAW3MMv7ZY_Q4OKSzH3c0Tdslkf2JtiHS3g52iz0O40Nyr7Vdwken95J8__D-29Wn4vrLx83Vu-vCcS1VwQCt0FUppLUlR7R1vZaohXIITFdYtnzdoFSuamQl2grrdd6m4cBLC7au-CV5dqy7j-HXlGcxvU8Ou84OGKZkpGSqEhqyURyNLoaUIrZmH31v48EwMAtksxA0C0GjhbmFbDY59uRUf6p7bM6hE9WsPz3pNjnbtdEOzqezjQvFmBD_us-hy8TTTTfNGM0ObTfucjOAdVlBwbSuQORfsdxP5djbYwwzwnyOaJK7xd_4iG40TfD_H_8vphSoNA</recordid><startdate>199504</startdate><enddate>199504</enddate><creator>Cathleen McCoy, M.</creator><creator>Katz, Vern L.</creator><creator>Gould, Natalie</creator><creator>Kuller, Jeffrey A.</creator><general>Elsevier Inc</general><general>The American College of Obstetricians and Gynecologists</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199504</creationdate><title>Non-immune hydrops after 20 weeks' gestation: Review of 10 years' experience with suggestions for management</title><author>Cathleen McCoy, M. ; Katz, Vern L. ; Gould, Natalie ; Kuller, Jeffrey A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3978-10ea495247aa23eeabb67e948ce0195e2f36de78c5d754f5eb6988d3032a0ab53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Algorithms</topic><topic>Amniocentesis</topic><topic>Biological and medical sciences</topic><topic>Delivery, Obstetric - methods</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gestational Age</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Hydrops Fetalis - diagnosis</topic><topic>Hydrops Fetalis - genetics</topic><topic>Hydrops Fetalis - mortality</topic><topic>Hydrops Fetalis - physiopathology</topic><topic>Hydrops Fetalis - therapy</topic><topic>Infant Mortality</topic><topic>Infant, Newborn</topic><topic>Karyotyping</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Parity</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome - epidemiology</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Puerperal Disorders - epidemiology</topic><topic>Survival Rate</topic><topic>Ultrasonography, Prenatal</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cathleen McCoy, M.</creatorcontrib><creatorcontrib>Katz, Vern L.</creatorcontrib><creatorcontrib>Gould, Natalie</creatorcontrib><creatorcontrib>Kuller, Jeffrey A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cathleen McCoy, M.</au><au>Katz, Vern L.</au><au>Gould, Natalie</au><au>Kuller, Jeffrey A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-immune hydrops after 20 weeks' gestation: Review of 10 years' experience with suggestions for management</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>1995-04</date><risdate>1995</risdate><volume>85</volume><issue>4</issue><spage>578</spage><epage>582</epage><pages>578-582</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><coden>OBGNAS</coden><abstract>To analyze the etiologies and outcomes for a southeastern section of the United States, and to organize an efficient approach to evaluation.
We reviewed 82 cases of non-immune hydrops presenting after 20 weeks' gestation over a 10-year period.
Overall perinatal mortality was 86.6%. Fetuses diagnosed with hydrops before 24 weeks' gestation had a perinatal mortality of 95%, with nearly one-third having abnormal karyotypes. The etiology of hydrops diagnosed after 24 weeks' gestation was more likely to remain idiopathic or to be related to cardiothoracic abnormalities.
Before 24 weeks' gestation, the high risk of mortality and abnormal karyotype justifies offering families funipuncture in the hope of finding a treatable cause of non-immune hydrops. After 24 weeks' gestation, when fewer abnormal karyotypes are found, funipuncture may also be pivotal in diagnosing the cause of non-immune hydrops.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>7898837</pmid><doi>10.1016/0029-7844(94)00444-I</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0029-7844 |
| ispartof | Obstetrics and gynecology (New York. 1953), 1995-04, Vol.85 (4), p.578-582 |
| issn | 0029-7844 1873-233X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77185490 |
| source | MEDLINE; Journals@Ovid Ovid Autoload |
| subjects | Adult Algorithms Amniocentesis Biological and medical sciences Delivery, Obstetric - methods Diseases of mother, fetus and pregnancy Female Follow-Up Studies Gestational Age Gynecology. Andrology. Obstetrics Humans Hydrops Fetalis - diagnosis Hydrops Fetalis - genetics Hydrops Fetalis - mortality Hydrops Fetalis - physiopathology Hydrops Fetalis - therapy Infant Mortality Infant, Newborn Karyotyping Male Medical sciences Parity Pregnancy Pregnancy Outcome - epidemiology Pregnancy. Fetus. Placenta Puerperal Disorders - epidemiology Survival Rate Ultrasonography, Prenatal |
| title | Non-immune hydrops after 20 weeks' gestation: Review of 10 years' experience with suggestions for management |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A05%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-immune%20hydrops%20after%2020%20weeks'%20gestation:%20Review%20of%2010%20years'%20experience%20with%20suggestions%20for%20management&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=Cathleen%20McCoy,%20M.&rft.date=1995-04&rft.volume=85&rft.issue=4&rft.spage=578&rft.epage=582&rft.pages=578-582&rft.issn=0029-7844&rft.eissn=1873-233X&rft.coden=OBGNAS&rft_id=info:doi/10.1016/0029-7844(94)00444-I&rft_dat=%3Cproquest_cross%3E77185490%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77185490&rft_id=info:pmid/7898837&rft_els_id=002978449400444I&rfr_iscdi=true |